TherapeuticsMD Announces First Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
TherapeuticsMD (TXMD) Reports Q1 Loss of $0.24/sh
May 15, 2023 4:34 PM EDTTherapeuticsMD (NASDAQ: TXMD) reported Q1 EPS of ($0.24), versus ($2.08) reported last year. Revenue for the quarter came in at $400 thousand, versus $700 thousand reported last year.
For earnings history and earnings-related data on TherapeuticsMD (TXMD) click here.
... More